Skip to main content
. 2018 Sep 14;29(9):904–910. doi: 10.1097/CAD.0000000000000683

Fig. 2.

Fig. 2

Kaplan–Meier estimates of the progression-free survival of patients with PD-L1 expression (N=130, median PFS did not reach the study endpoint, P=0.018). PD-L1, programmed death ligand-1; PFS, progression-free survival.